HiReyTSRA-808
An investigational sickle cell disease therapy using in vivo lipid nanoparticle delivery to hematopoietic stem cells.
About
An investigational sickle cell disease therapy using in vivo lipid nanoparticle delivery to hematopoietic stem cells.
Not on HiRey yet
Are you on the Tessera Therapeutics team? Claim it